Generic platelet drug put to the test: will it match the original?
NCT ID NCT06768619
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checked whether a generic eltrombopag olamine tablet works the same as the brand-name version in 36 healthy Chinese adults after a meal. Participants took a single dose of each formulation in random order, and researchers measured how the drug moved through their bodies. The goal was to confirm bioequivalence, which could lead to a more affordable option for treating low platelet counts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
eltrombopag olamine (a drug that boosts platelet production)
What this could lead to
If successful, this could confirm that the generic tablet is equivalent to the brand-name drug, offering a more affordable treatment option for people with low platelet counts.
What could go wrong
This is a small, early-stage bioequivalence study in healthy people, not patients. It does not test whether the drug actually improves health outcomes, and results may not predict real-world effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changchun University of Traditional Chinese Medicine Affiliated Hospital
Changchun, Jilin, 130021, China